Tang Wenlu

Tang Wenlu has established herself as a prominent researcher in clinical pharmacology at Fudan University's School of Pharmacy. Her academic credentials include a Bachelor's in Clinical Medicine, Master's in Clinical Pharmacology, and Doctor of Medicine in Clinical Pharmacology. As the Principal Investigator of the Evidence-Based Drug Therapy Research Group at Fudan University's School of Pharmacy, she leads important research initiatives in evidence-based medicine and drug therapy. Her expertise is recognized through her role as a Reviewer for the prestigious Cochrane Hypertension Group, contributing to systematic reviews and meta-analyses that shape clinical practice guidelines. Her work bridges the gap between clinical medicine and pharmacology, focusing on developing evidence-based approaches to drug therapy. As an Associate Professor, she combines her clinical background with research expertise to advance the field of clinical pharmacology and improve patient care through evidence-based practices